at La Jolla, California and other locations
study started
estimated completion:
David Piccioni



The NeuroBlate® System (NBS) is a minimally invasive robotic laser thermotherapy tool that is being manufactured by Monteris Medical. Since it received FDA clearance in May 2009, the NBS has been used in over 1300 procedures conducted at approximately 56 leading institutions across United States. This is a prospective, multi-center registry that will include data collection up to 12 months to evaluate procedural success, local control failure rate, and QoL in up to 1,000 patients and up to 50 sites. Currently, the study has 162 subjects enrolled from 14 active sites

Official Title

Laser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate System (LAANTERN) Prospective Registry


Metastatic Brain Tumor Primary Brain Tumor Procedural Success Progression Quality of Life Brain Neoplasms NeuroBlate System


You can join if…

  1. Patient or legally authorized representative provides written authorization and/or consent per institution and geographical requirements
  2. Patient who is to undergo thermal therapy by the NeuroBlate® System for treatment of their neurological disorder

You CAN'T join if...

  1. Patient who is, or is expected to be inaccessible for follow-up
  2. Patient meets any exclusion criteria required by local law (e.g. age)
  3. Other concurrent medical or other condition (chronic or acute in nature) that in the opinion of the investigator may prevent participation or otherwise render patient ineligibility for the study


  • University of California, San Diego accepting new patients
    La Jolla California 92093 United States
  • Barrow Neurological Institute at Dignity Health St. Joseph's Hospital & Medical Center accepting new patients
    Phoenix Arizona 85013 United States

Lead Scientist


accepting new patients
Start Date
Completion Date
Monteris Medical
Study Type
Last Updated